EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma

Yanhe An, Na Luo

International Journal of Molecular Sciences · 12.12.2025 · 26 (24) · 11986

DOI: 10.3390/ijms262411986 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.12.2025. Verfasst von Yanhe An und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Histology, School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Projects, Tianjin Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) represents the predominant histological subtype of renal cell carcinoma (RCC), constituting approximately 85% of all RCC cases. Recent advancements in therapies aimed at targeting angiogenesis have marked a significant breakthrough in the treatment of ccRCC, with several of these therapies receiving approval for clinical use. Furthermore, the introduction of immune checkpoint inhibitors (ICIs) has demonstrated efficacy in the management of ccRCC. Nonetheless, there is an urgent need for the identification of predictive and prognostic biomarkers, which are currently under investigation. This review offers an extensive examination of the pathological, genomic, and molecular characteristics of ccRCC, with particular emphasis on its immune attributes. Additionally, it addresses the clinical implications of targeted therapies and immunotherapies, whether administered as monotherapy or in combination with traditional or novel agents, while also evaluating the results of pertinent clinical trials. By encompassing a wide range of topics related to ccRCC, from foundational knowledge to clinical applications, this review aims to deepen the understanding of the essential features of ccRCC and to establish a theoretical basis for the formulation of clinical strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellImmune Checkpoint InhibitorsKidney NeoplasmsHumansImmunotherapyBiomarkers, Tumor

Stichwörter der Autor:innen

clear cell renal cell carcinomaimmune checkpoint inhibitorstargeting therapy

Substanzen

Immune Checkpoint InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Anatomy and Histology, School of Medicine, Nankai University, Tianjin 300071, China.

Förderung

  • Scientific Research Projects, Tianjin Municipal Education Commission

Zitieren

APA

An, Y., & Luo, N. (2025). Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences, 26(24), 11986. https://doi.org/10.3390/ijms262411986

Vancouver

An Y, Luo N. Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 2025;26(24):11986. doi:10.3390/ijms262411986

BibTeX
@article{An2025,
  author = {An, Yanhe and Luo, Na},
  title = {Immune Landscape and Application of Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {11986},
  doi = {10.3390/ijms262411986}
}
Kostenlos starten →